Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ?
White NJ. et al, (2025), Malar J, 24
Dose-Optimization of a Novel Co-Formulated Triple Combination Antimalarial Therapy: Artemether-Lumefantrine-Amodiaquine.
Tarning J. et al, (2025), Clin Pharmacol Ther, 117, 1248 - 1253
Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.
Watson JA. et al, (2025), Antimicrob Agents Chemother, 69
Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A case-cohort study of 4,352 women on the Thailand-Myanmar border.
Gilder ME. et al, (2025), PLoS Med, 22
A comparison of national seasonal influenza treatment guidelines across the Asia Pacific region.
Beer E. et al, (2025), PLOS Glob Public Health, 5
Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial.
Mehra S. et al, (2024), Proc Natl Acad Sci U S A, 121
Evidence that remdesivir treatment reduces viral titers in patients with COVID-19.
Boyd S. et al, (2024), Antimicrobial agents and chemotherapy
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Commons RJ. et al, (2024), Lancet Child Adolesc Health, 8, 798 - 808
Author Correction: Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2024), Sci Rep, 14
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.
Tarning J. et al, (2024), Malar J, 23
Rectal artesunate: lives not saved.
White NJ. et al, (2024), Trans R Soc Trop Med Hyg, 118, 639 - 641
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever.
Ding J. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Wongnak P. et al, (2024), Lancet Infect Dis, 24, 953 - 963
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2024), Nat Commun, 15